Skip to content

Public title of study to evaluate the efficacy of rasonadi vati in the management of Uchharaktachapa with special reference to essential hypertension

RANDOMISED OPEN CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF RASONADI VATI IN THE MANAGEMENT OF UCHHARAKTACHAP W.S.R.TO ESSENTIAL HYPERTENSION - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083474
Enrollment
80
Registered
2025-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Dr Asavari Sanjay More
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of essential hypertension with SBP less than 159mmHg and greater than equal to 140mmHg and DBP less than equal to 99mmHg to 90 mmHg Patients who are know case of essential hypertension with their ongoing allopathic medicine

Exclusion criteria

Exclusion criteria: Patient who have a past history of Atrial Fibrillation, Acute coronary syndrome, Myocardial Infarction, Arrhythmia in the last 6 months. Symptomatic patient with clinical evidence of CCF Secondary Hypertension Patient with concurrent serious hepatic or Renal or uncontrolled led pulmonary dysfunction or other concurrent severe diseases Patient with Diabetes Mellitus Women who are lactating or pregnant Patient on steroids, oral contraceptive pills, or oestrogen replacement therapy. Alcoholic and /or drug abusers. Patient with evidence of malignancy. Patient suffering from major systemic illness necessitating long term drug treatment ( Rheumatic Arthritis ,Endocrine disorders) H/o Hypersensitivity to any of the Trial drugs or their ingredients.

Design outcomes

Primary

MeasureTime frame
To assess the effect of Rasonadi vati 500MG Twice in Day (Vyan - Udan) for 30 days in Uchharaktachapa w.s.r to esssential hypertension. Timepoint: To study change in symptoms of uchharaktachap such as shirshool,bhrama etc after 3 weeks To observe changes in blood pressure of patient at 1st week and at 3rd week

Secondary

MeasureTime frame
To observe the change in BP of patient over a period of 30 days 2 To study the change in symptoms of uchharaktachapa like bhrama, daurbalya, ayasen shwas, anidra ,shirshool etc over a period of 30days 3 To study Uchharaktachapa in ayurveda perspective 4 To study the Essential hypertension according to modern science 5 To study the drug Rasonadi vati in detail Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Asavari Sanjay More

Yashwant Ayurvedic College PGT and RC kodoli

suryakiran_wagh@rediffmail.com9822846910

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026